Log In
Tuesday 19th June 2018

Bone drugs linked to oesophageal cancer

3rd September 2010

Oxford University research has suggested that the long term used of bone-strengthening drugs used to treat fractures could increase the risk of oesophageal cancer.

A study of 3,000 people found that those taking bisphosphonates for five years upped the risk from one in 1,000 to two in 1,000 for 60 to 79-year-olds. The findings, which have been published in the British Medical Journal, were based on an analysis of anonymised GP records. Cancer Research UK said the findings should be treated with caution, pointing out the risks were "still small".


Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

M3 - For secure managed hosting over N3 or internet
© Mayden Foundation 2018